TradeLink Capital’s Tenet Healthcare THC Stock Holding History

TradeLink Capital’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-5,300	Closed	-$245K	–	388
2013 Q2	$245K	Buy	+5,300	New	+$237K	0.08%	257

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

TradeLink Capital's THC Position: Q3 2013 in Review

TradeLink Capital sold out of Tenet Healthcare (THC) in Q3 2013, closing a stake of 5,300 shares — an estimated $245K sold.

TradeLink Capital first reported a position in THC in Q2 2013 and held it in 1 quarter. The position peaked at $245K in Q2 2013. 270 funds tracked by Wall St. Rank hold THC as of Q3 2013.

TradeLink Capital reported no remaining Tenet Healthcare position as of Q3 2013 after selling out during the quarter.
TradeLink Capital sold 5,300 Tenet Healthcare shares in Q3 2013, an estimated $245K.
TradeLink Capital first reported a position in Tenet Healthcare in Q2 2013 and held it in 1 quarter.
TradeLink Capital's Tenet Healthcare position peaked at $245K in Q2 2013.
270 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2013.

Based on TradeLink Capital's 13F filing for Q3 2013, filed 12 Nov 2013.